Home › Rhabdomyosarcoma › Maryland
Rhabdomyosarcoma clinical trials in Maryland
4 studies for Rhabdomyosarcoma are looking for participants at sites in Maryland.
Cities in Maryland
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 3 to 39 · All sexes · Updated Sep 29, 2026 · NCT06865664A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Sinai Hospital of Baltimore, Baltimore
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT07466316Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
- Johns Hopkins Hospital, Baltimore
Recruiting
Up to age 39 · All sexes · Updated Jul 13, 2026 · NCT06796543Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RecruitingPhase 2
Ages 1 to 50 · All sexes · Updated Mar 13, 2026 · NCT01804634From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.